Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Socioeconomic Inequality in the Use of Rituximab Therapy Among Non-Hodgkin Lymphoma Patients in Chinese Public Hospitals

    Access Status
    Fulltext not available
    Authors
    Huang, Y.
    Zhang, M.
    Xu Xiang, X.
    Xu, X.
    Zhou, Q.
    Jian, Le
    Date
    2012
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Huang, Yu-Wen and Zhang, Mei-Bian and Xu Xiang, Xiang and Xu, Xiao-Hua and Zhou, Quan and Jian, Le. 2012. Socioeconomic Inequality in the Use of Rituximab Therapy Among Non-Hodgkin Lymphoma Patients in Chinese Public Hospitals. Asia-Pacific Journal of Public Health. 26 (2): pp. 203-214..
    Source Title
    Asia-Pacific Journal of Public Health
    DOI
    10.1177/1010539512464648
    ISSN
    1941-2479
    URI
    http://hdl.handle.net/20.500.11937/44224
    Collection
    • Curtin Research Publications
    Abstract

    Background. Rituximab is a patient-paid effective monoclonal-antibody drug for non-Hodgkin lymphoma (NHL). Little is known in China, a country with unequal distribution of wealth and medical insurance systems, about the impact of socioeconomic status (SES) on selecting rituximab therapy in NHL patients. Methods. A total of 328 NHL inpatients in 2 public hospitals in Hangzhou were recruited and divided into 2 equal groups: with rituximab therapy and with no rituximab therapy group. Results. Selection and frequency of rituximab therapy increased with duration of education and in urban citizens (P < .01). Officers and businessmen were more likely to use rituximab therapy compared with farmers (P < .01). Patients covered by Urban Employee Basic Medical Insurance were more likely to select rituximab therapy than those insured with Urban-Rural Residents Basic Medical Insurance (P < .01). Conclusion. There was an inequality in provision of rituximab therapy among Chinese NHL patients, and this was associated with differences in SES status. Effective measures are suggested to ameliorate the inequality issue.

    Related items

    Showing items related by title, author, creator and subject.

    • Cost of cancer care for patients undergoing chemotherapy: The Elements of Cancer Care study
      Ward, R.; Laaksonen, M.; Van Gool, K.; Pearson, S.; Daniels, B.; Bastick, P.; Norman, Richard; Hou, C.; Haywood, P.; Haas, M. (2015)
      Aim: To determine the monthly treatment costs for each element of cancer care in patients receiving chemotherapy and to apportion the burden of cost by financing agent (Commonwealth, State government, private health ...
    • Health insurance in developing countries : willingness to pay for health insurance in Thailand using discrete choice experiment methods
      Nanna, Anoo (2011)
      In Thailand, a universal health insurance coverage policy was implemented in 2001 alongside the reform of public health insurance. Since the reform, Thailand has had three major public health insurance schemes of the ...
    • Effect of private insurance incentive policy reforms on trends in coronary revascularisation procedures in the private and public health sectors in Western Australia: A cohort study
      Trafalski, S.; Briffa, T.; Hung, J.; Moorin, Rachel; Sanfilippo, F.; Preen, D.; Einarsdottir, K. (2013)
      Background: The Australian federal government introduced private health insurance incentive policy reforms in 2000 that increased the uptake of private health insurance in Australia. There is currently a lack of evidence ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.